Bacterial enzyme identified that may reduce antibiotic resistance in MRSA and other pathogens

Human bodies are home to billions of bacteria, most of which are harmless or even beneficial, said Vijay Parashar, associate professor of medical and molecular sciences at the University of Delaware College of Health Sciences. “It sounds gross, but not all bacteria are bad; most of them are good,” he explained. Parashar highlighted that the real concern arises when pathogenic bacteria acquire the ability to evade antibiotics, a phenomenon that has become increasingly common in recent years.

Researchers at the University of Delaware have been studying the mechanisms by which these harmful microbes develop resistance, including the exchange of genetic material that confers protective traits. Their work underscores the importance of judicious antibiotic use and the development of new therapeutic strategies. The findings also emphasize the delicate balance within the human microbiome, where beneficial bacteria play a crucial role in health while pathogenic strains pose a growing threat.

As antibiotic resistance continues to rise globally, insights from scientists like Parashar are vital for guiding public health policies and clinical practices. Continued research into bacterial behavior and resistance mechanisms will be essential to safeguard the effectiveness of existing treatments and to develop new approaches to combat infectious diseases.